Crossmark Global Holdings’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.62M | Buy |
20,936
+67
| +0.3% | +$18.5K | 0.06% | 275 |
|
|
2026
Q1 | $6.16M | Buy |
20,869
+1,192
| +6% | +$354K | 0.09% | 226 |
|
|
2025
Q4 | $5.37M | Buy |
19,677
+625
| +3% | +$170K | 0.08% | 242 |
|
|
2025
Q3 | $5.15M | Buy |
19,052
+482
| +3% | +$131K | 0.08% | 248 |
|
|
2025
Q2 | $5.12M | Buy |
18,570
+1,554
| +9% | +$423K | 0.08% | 246 |
|
|
2025
Q1 | $4.51M | Buy |
17,016
+161
| +1% | +$39.7K | 0.08% | 248 |
|
|
2024
Q4 | $3.92M | Sell |
16,855
-1,570
| -9% | -$361K | 0.07% | 273 |
|
|
2024
Q3 | $4.07M | Sell |
18,425
-395
| -2% | -$81.7K | 0.07% | 271 |
|
|
2024
Q2 | $3.7M | Sell |
18,820
-344
| -2% | -$71.1K | 0.07% | 280 |
|
|
2024
Q1 | $4.13M | Sell |
19,164
-854
| -4% | -$179K | 0.08% | 262 |
|
|
2023
Q4 | $4.22M | Sell |
20,018
-262
| -1% | -$55.9K | 0.09% | 244 |
|
|
2023
Q3 | $4.38M | Sell |
20,280
-502
| -2% | -$99.8K | 0.1% | 227 |
|
|
2023
Q2 | $4.14M | Buy |
20,782
+211
| +1% | +$39K | 0.09% | 247 |
|
|
2023
Q1 | $3.94M | Sell |
20,571
-693
| -3% | -$125K | 0.09% | 245 |
|
|
2022
Q4 | $3.58M | Buy |
21,264
+1,215
| +6% | +$211K | 0.09% | 253 |
|
|
2022
Q3 | $3.55M | Sell |
20,049
-1,766
| -8% | -$349K | 0.1% | 232 |
|
|
2022
Q2 | $4.47M | Sell |
21,815
-4,853
| -18% | -$1.03M | 0.12% | 207 |
|
|
2022
Q1 | $6.34M | Buy |
26,668
+6,486
| +32% | +$1.52M | 0.14% | 177 |
|
|
2021
Q4 | $4.61M | Sell |
20,182
-243
| -1% | -$53.5K | 0.1% | 214 |
|
|
2021
Q3 | $3.95M | Buy |
20,425
+440
| +2% | +$89.1K | 0.09% | 227 |
|
|
2021
Q2 | $4.25M | Buy |
19,985
+161
| +0.8% | +$34K | 0.1% | 220 |
|
|
2021
Q1 | $4.05M | Sell |
19,824
-665
| -3% | -$131K | 0.1% | 219 |
|
|
2020
Q4 | $3.73M | Sell |
20,489
-144
| -0.7% | -$24.5K | 0.09% | 233 |
|
|
2020
Q3 | $3.45M | Sell |
20,633
-287
| -1% | -$48.3K | 0.1% | 227 |
|
|
2020
Q2 | $3.4M | Buy |
20,920
+467
| +2% | +$83.7K | 0.1% | 229 |
|
|
2020
Q1 | $3.54M | Sell |
20,453
-74
| -0.4% | -$14.7K | 0.13% | 185 |
|
|
2019
Q4 | $4.12M | Sell |
20,527
-401
| -2% | -$82.3K | 0.11% | 211 |
|
|
2019
Q3 | $4.42M | Sell |
20,928
-1,540
| -7% | -$322K | 0.13% | 195 |
|
|
2019
Q2 | $4.36M | Buy |
22,468
+330
| +1% | +$60.8K | 0.12% | 202 |
|
|
2019
Q1 | $3.64M | Sell |
22,138
-125
| -0.6% | -$22.1K | 0.1% | 230 |
|
|
2018
Q4 | $4.19M | Sell |
22,263
-1,900
| -8% | -$351K | 0.13% | 196 |
|
|
2018
Q3 | $4.11M | Sell |
24,163
-1,637
| -6% | -$276K | 0.1% | 234 |
|
|
2018
Q2 | $4.23M | Sell |
25,800
-974
| -4% | -$159K | 0.11% | 216 |
|
|
2018
Q1 | $4.33M | Sell |
26,774
-2,267
| -8% | -$361K | 0.11% | 222 |
|
|
2017
Q4 | $4.24M | Buy |
29,041
+750
| +3% | +$107K | 0.1% | 240 |
|
|
2017
Q3 | $3.84M | Buy |
+28,291
| New | +$3.57M | 0.1% | 246 |
|
|
2016
Q3 | $3.84M | Buy |
+28,291
| New | +$2.95M | 0.1% | 246 |
|
Other funds holding CME
Crossmark Global Holdings's CME Position: Q2 2026 in Review
Crossmark Global Holdings increased its CME Group (CME) stake by 0.32% in Q2 2026, buying an estimated $18.5K and bringing the position to 20,936 shares worth $4.62M. The position accounts for 0.06% of the portfolio, ranked #275.
Crossmark Global Holdings first reported a position in CME in Q3 2016 and has held it in 37 quarters since. The position peaked at $6.34M in Q1 2022. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Crossmark Global Holdings held 20,936 shares of CME Group worth $4.62M as of Q2 2026.
- Crossmark Global Holdings bought 67 CME Group shares in Q2 2026, an estimated $18.5K.
- CME Group made up 0.06% of Crossmark Global Holdings's portfolio in Q2 2026, its #275 holding.
- Crossmark Global Holdings first reported a position in CME Group in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's CME Group position peaked at $6.34M in Q1 2022.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.